Korea Pharma Co (XKRX:032300) Asset Impairment Charge : ₩0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Korea Pharma Co Asset Impairment Charge?

Korea Pharma Co's Asset Impairment Charge for the three months ended in Mar. 2025 was ₩0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was ₩0 Mil.

Korea Pharma Co Asset Impairment Charge Historical Data

The historical data trend for Korea Pharma Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Pharma Co Asset Impairment Charge Chart

Korea Pharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Asset Impairment Charge

Get a 7-Day Free Trial

Korea Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Korea Pharma Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

Korea Pharma Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Korea Pharma Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Korea Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Pharma Co Ltd (XKRX:032300) » Definitions » Asset Impairment Charge

Traded in Other Exchanges

N/A

Address

8th Floor, 14, Teheran-ro 4-gil, Gangnam-gu, Seoul, KOR

Website

http://www.koreapharma.co.kr

Korea Pharma Co Ltd is a drug manufacturer. The company's products include amino acid drugs; antibiotic drugs; antidotal drugs; antiepileptic drugs; antihistamine drugs; anti-inflammatory drugs; antimicrobial drugs; antiplatelet drugs; circulatory system drugs; cns drugs; dermatological drugs; endocrine drugs; gastrointestinal drugs; hepatic drugs; hormonal drugs; multivitamins; respiratory drugs; skeltal muscle relaxants; specialty drugs; sympathomimetic drugs; and vitamin b1.

Korea Pharma Co Headlines

No Headlines